Pancreatic Neuroendocrine Neoplasms

Historical background and epidemiology.- Radiological diagnosis.- Nuclear medicine diagnosis.- Endocrinological approach to diagnosis.- Cytological diagnosis.- Classification.- Immunohistochemical approach to diagnosis.- Insulinoma.- Glucagonoma.- Somatostatinoma.- VIPoma.- Gastrinoma.- ACTH-producing tumor.- Serotonin-producing tumor.- GRF-, GH-, Ghrelin- and PTH-producing tumor.- Nonfunctioning pancreatic neuroendocrine neoplasms including PP-, calcitonin- and neurotensin-producing tumors.- Poorly differentiated neuroendocrine carcinoma of the pancreas.- Mixed adenoneuroendocrine carcinoma of the pancreas.- Hyperplastic and dysplastic pancreatic neuroendocrine lesions.- Molecular pathology.- Surgical therapy.- Pharmacological therapy.

Stefano La Rosa. In 1998 he joined the Department of Pathology, Ospedale di Circolo, Varese, Italy and in the following years was appointed Assistant Professor of Pathology at the University of Insubria, Varese. Dr. La Rosa's main field of interest is neuroendocrine pathology, with special reference to neuroendocrine tumors of the gut and pancreas. He is a member of the editorial boards of Frontiers in Pathology and Advances in Medicine, as well as a reviewer for many other journals. His awards include the Leonardo Mosca Award and the Cesare Biancifiori Award from the Italian Division of the International Academy of Pathology. He is member of the following scientific societies: European Society of Pathology (ESP), International Academy of Pathology (IAP), Società Italiana di Anatomia Patologica e di Citopatologia Diagnostica (SIAPEC), United States & Canadian Academy of Pathology (USCAP), Endocrine Pathology Society, European Neuroendocrine Tumor Society (ENETS), Associazione Italiana per i Tumori Neuroendocrini (ITANET) and Italian Association of Rare Tumors (IART). He is the secretary of the Endocrine Working Group of the ESP and is the head or co-author of more than 100 papers including original articles and book chapters.

"The purpose is to comprehensively present pancreatic neuroendocrine tumors from both a clinical and pathological standpoint. In particular, the book aims to cover the advances in diagnosis and treatment that have occurred over the past decade. This book is written for both clinicians and pathologists who have a particular interest in the management or diagnosis of pancreatic neuroendocrine tumors. Pathology residents or oncology fellows with a particular interest in these tumors also could find this book of value." (Kyle D. Perry, Doody's Book Reviews, September, 2015)